PAL
Click for more information
0.00% 29.5¢ palla pharma limited

Ann: Palla Pharma Investor Presentation - FY19 Results & Outlook, page-18

  1. Alee26
    2,249 Posts.
    lightbulb Created with Sketch. 258
    clock Created with Sketch.
    30/03/20
    19:19
    Post #: 43782391
    Next few years will be ridden with nasty surprises and losses. Debt will weigh on them. No profits and another one CR in order to survive. Total laggard.
    Last edited by Alee26: 30/03/20
    PAL Price at posting: 48.0¢ Sentiment: Sell Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.